This industry has been encumbered with paper since its inception, ridiculously large volumes of paper. Paper-oriented case report forms have to be sent from physicians to pharmaceutical companies and entered twice, for quality reasons, into a database. Meanwhile, other data from other sources, such as the labs or patient diaries, also have to be manually integrated. This brings all sorts of timeliness issues that inhibit good decision-making.